Aprea Therapeutics Reaches Analyst Target Price
August 25, 2021 at 08:45 AM EDT
In recent trading, shares of Aprea Therapeutics Inc (APRE) have crossed above the average analyst 12-month target price of $4.00, changing hands for $4.06/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgrade on valuation, or, re-adjust their target price to a higher level..